SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma
Aurobindo Pharma
BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 27, 11:15
1087.30
6.1 (0.56%)
VOLUME 24,195
LIVE
NSE
Nov 27, 11:15
1088.00
5.7 (0.53%)
VOLUME 309,773
News on Aurobindo Pharma
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Top buzzing midcap stocks to trade on November 26 

12.49 pm | 26 Nov 2014 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Torrent Power, GVK, Reliance Power, GMR Infrastructure...

Aurobindo Pharma down 3% on recall of epilepsy drug in US

12.26 pm | 26 Nov 2014 |  Source: Moneycontrol.com

Aurobindo Pharma USA said it had not received any reports of patient complications, but said it had has received four complaints for empty capsules...

Aurobindo Pharma tanks 3% on plans to raise USD 350 mn

12.19 pm | 26 Nov 2014 |  Source: PTI

The Hyderabad-based firm features among the top ten companies in India in terms of consolidated revenues. It exports to over 125 countries across the ...

Stocks in news: GMR, Financial Tech, DLF, Tata Coffee

8.24 am | 26 Nov 2014 |  Source: Moneycontrol.com

Stocks in news: GMR | MRF | Financial Technologies | Greenply industries | South Indian Bank | DLF | Omaxe | Aurobindo Pharma and Tata Coffee are stoc...

Aurobindo Pharma: Outcome of board meeting

9.55 pm | 25 Nov 2014 |  Source: Moneycontrol.com

Aurobindo Pharma in its Meeting held on November 25, 2014, has considered and approved raising of the funds by the Company through Issue of Securities...

Aurobindo Pharma's subsidiary recalls epilepsy drug in US

7.19 pm | 25 Nov 2014 |  Source: PTI

The company said it has not received any reports of adverse events related to this recall to date, but has received four complaints for empty capsules...

Buy Aurobindo Pharma, says Rahul Arora 

1.57 pm | 25 Nov 2014 |  Source: CNBC-TV18

Rahul Arora, CEO at Nirmal Bang Institutional Equities is of the view that one may buy Aurobindo Pharma....

Stocks in news: Bharti, HDFC Bank, Amtek Auto, SpiceJet

8.34 am | 25 Nov 2014 |  Source: CNBC-TV18

Bharti Airtel | HDFC Bank | Jaiprakash Associates | Reliance Capital | Reliance Power | Tata Motors | Kotak Mahindra Bank | Ashok Leyland | ING Vysya ...

Aurobindo Pharma: Board meeting on Nov 25, 2014

5.14 pm | 21 Nov 2014 |  Source: Moneycontrol.com

Aurobindo Pharma has informed that a meeting of the Board of Directors of the Company will be held on November 25, 2014, to consider raising of funds ...

Buy Dr Reddy's, Aurobindo Pharma: Sudarshan Sukhani 

10.57 am | 20 Nov 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Laboratories and Aurobindo Pharma....

Do not short Nifty today; buy Wipro, ICICI Bank: Sukhani 

9.58 am | 20 Nov 2014 |  Source: CNBC-TV18

For Bank Nifty our stop loss was 17500, that it still holds so you hold on to your positions, says Sukhani....

Stay invested in Aurobindo Pharma: Hemen Kapadia 

3.52 pm | 13 Nov 2014 |  Source: CNBC-TV18

Hemen Kapadia, VP at KR Choksey Securities is of the view that one may hold Aurobindo Pharma....

Aurobindo Pharma up 4%; US arm highest bidder to buy Natrol

10.54 am | 12 Nov 2014 |  Source: Moneycontrol.com

The acquisition, however, is subject to final approval by the US Court and other statutory approvals as may be required, including any termination of ...

Aurobindo to buy US nutritional supplements maker for $133m

10.54 am | 12 Nov 2014 |  Source: Reuters

Aurobindo said the deal with Chatsworth, California-based Natrol, which sells vitamins and supplements as well as diet and weight management products,...

Aurobindo Pharma USA emerges as best bidder to acquire Natrol

10.08 am | 12 Nov 2014 |  Source: Moneycontrol.com

Aurobindo Pharma's 100% subsidiary, Aurobindo Pharma USA Inc. emerged as the highest bidder for acquisition of nutritional supplement maker, Natrol In...

Is Sun Pharma expensive at current valuations? 

4.20 pm | 11 Nov 2014 |  Source: CNBC-TV18

Purely from a short-term point of view there might not be too much of significant run up but purely on a fundamental basis Sun Pharma looks fairly str...

Sun Pharma a must in core portfolio: Experts 

3.38 pm | 11 Nov 2014 |  Source: CNBC-TV18

Market experts Nipun Mehta and Dilip Bhatdo see no negatives for Sun Pharma if the Ranbaxy deal goes through....

Aurobindo Pharma at record high, up 4% on Q2 performance

1.49 pm | 07 Nov 2014 |  Source: Moneycontrol.com

Consolidated revenue grew by 50.5 percent to Rs 2,881 crore in the quarter ended September 2014 compared to Rs 1,914 crore in the same quarter last ye...

Aurobindo Pharma Q2 net up 58% to Rs 372 cr on US generics

12.16 pm | 07 Nov 2014 |  Source: Moneycontrol.com

"The quarterly performance has been satisfactory mainly on account of overall growth led by US Generics. Our business deliveries in Europe as well as ...

Bullish on mkt; buy pvt banks, short Hindalco: CK Narayan 

9.37 am | 07 Nov 2014 |  Source: CNBC-TV18

CK Narayan of Growth Avenues says it has become a very stock specific market. He is very bullish on private banks like Kotak Mahindra Bank and Axis Ba...

1 2 3 4 5
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.